CRISPR Therapeutics AG logo

CRISPR Therapeutics AG

NASDAQ:CRSP

Overview | Financials
Company Name CRISPR Therapeutics AG
Symbol CRSP
Currency USD
Price 41.99
Market Cap 3,601,671,255
Dividend Yield 0%
52-week-range 36.52 - 75.91
Industry Biotechnology
Sector Healthcare
CEO Dr. Samarth Kulkarni Ph.D.
Website https://www.crisprtx.com

An error occurred while fetching data.

About CRISPR Therapeutics AG

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio

Related Stocks

QuidelOrtho Corporation logo

QuidelOrtho Corporation

QDEL

35.6 USD

iRhythm Technologies, Inc. logo

iRhythm Technologies, Inc.

IRTC

97.77 USD

ICU Medical, Inc. logo

ICU Medical, Inc.

ICUI

140.19 USD

Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

TNDM

18.18 USD

Apellis Pharmaceuticals, Inc. logo

Apellis Pharmaceuticals, Inc.

APLS

24.37 USD

The Ensign Group, Inc. logo

The Ensign Group, Inc.

ENSG

125.47 USD

Cerevel Therapeutics Holdings, Inc. logo

Cerevel Therapeutics Holdings, Inc.

CERE

44.96 USD

Medpace Holdings, Inc. logo

Medpace Holdings, Inc.

MEDP

317.93 USD

Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc.

LNTH

99.29 USD

Financials

Numbers are in millions USD

Numbers are in millions USD